 | • レポートコード：MRC23Q31644 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2-3日） • 産業分類：化学＆材料 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のドフェティリドAPI市場について調査・分析し、世界のドフェティリドAPI市場概要、メーカー別競争状況、地域別生産量、地域別消費量、タイプ別セグメント分析（99.0%以上、98.0%以上）、用途別セグメント分析（カプセル、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Farmak A.S、ChemWerth Inc、Sun Pharmaceutical Industries Ltd.、Avet Pharmaceuticals Inc.、Midas Pharma、DQA Pharmaなどが含まれています。世界のドフェティリドAPI市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間中の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争による影響は、ドフェティリドAPI市場規模を推定する際に考慮しました。本レポートは、ドフェティリドAPIの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ドフェティリドAPIに関するビジネス上の意思決定に役立てることを目的としています。 ・ドフェティリドAPI市場の概要 - 製品の定義 - ドフェティリドAPIのタイプ別セグメント - 世界のドフェティリドAPI市場成長率のタイプ別分析（99.0%以上、98.0%以上） - ドフェティリドAPIの用途別セグメント - 世界のドフェティリドAPI市場成長率の用途別分析（カプセル、その他） - 世界市場の成長展望 - 世界のドフェティリドAPI生産量の推定と予測（2018年-2029年） - 世界のドフェティリドAPI生産能力の推定と予測（2018年-2029年） - ドフェティリドAPIの平均価格の推定と予測（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - ドフェティリドAPI市場の競争状況およびトレンド ・ドフェティリドAPIの地域別生産量 - ドフェティリドAPI生産量の地域別推計と予測（2018年-2029年） - 地域別ドフェティリドAPI価格分析（2018年-2023年） - 北米のドフェティリドAPI生産規模（2018年-2029年） - ヨーロッパのドフェティリドAPI生産規模（2018年-2029年） - 中国のドフェティリドAPI生産規模（2018年-2029年） - 日本のドフェティリドAPI生産規模（2018年-2029年） - 韓国のドフェティリドAPI生産規模（2018年-2029年） - インドのドフェティリドAPI生産規模（2018年-2029年） ・ドフェティリドAPIの地域別消費量 - ドフェティリドAPI消費量の地域別推計と予測（2018年-2029年） - 北米のドフェティリドAPI消費量（2018年-2029年） - アメリカのドフェティリドAPI消費量（2018年-2029年） - ヨーロッパのドフェティリドAPI消費量（2018年-2029年） - アジア太平洋のドフェティリドAPI消費量（2018年-2029年） - 中国のドフェティリドAPI消費量（2018年-2029年） - 日本のドフェティリドAPI消費量（2018年-2029年） - 韓国のドフェティリドAPI消費量（2018年-2029年） - 東南アジアのドフェティリドAPI消費量（2018年-2029年） - インドのドフェティリドAPI消費量（2018年-2029年） - 中南米・中東・アフリカのドフェティリドAPI消費量（2018年-2029年） ・タイプ別セグメント：99.0%以上、98.0%以上 - 世界のドフェティリドAPIのタイプ別生産量（2018年-2023年） - 世界のドフェティリドAPIのタイプ別生産量（2024年-2029年） - 世界のドフェティリドAPIのタイプ別価格 ・用途別セグメント：カプセル、その他 - 世界のドフェティリドAPIの用途別生産量（2018年-2023年） - 世界のドフェティリドAPIの用途別生産量（2024年-2029年） - 世界のドフェティリドAPIの用途別価格 ・主要企業のプロファイル：企業情報、製品ポートフォリオ、生産量、価格、動向 Farmak A.S、ChemWerth Inc、Sun Pharmaceutical Industries Ltd.、Avet Pharmaceuticals Inc.、Midas Pharma、DQA Pharma ・産業チェーンと販売チャネルの分析 - ドフェティリドAPI産業チェーン分析 - ドフェティリドAPIの主要原材料 - ドフェティリドAPIの販売チャネル - ドフェティリドAPIのディストリビューター - ドフェティリドAPIの主要顧客 ・ドフェティリドAPI市場ダイナミクス - ドフェティリドAPIの業界動向 - ドフェティリドAPI市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Dofetilide is an oral class III antiarrhythmic agent used for treatment and prevention of atrial fibrillation and flutter. The active pharmaceutical ingredient (API) is the part of any drug that produces the intended effects.
The global Dofetilide API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Dofetilide API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Dofetilide API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Dofetilide API include Farmak A.S, ChemWerth Inc, Sun Pharmaceutical Industries Ltd., Avet Pharmaceuticals Inc., Midas Pharma and DQA Pharma, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dofetilide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dofetilide API.
The Dofetilide API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Dofetilide API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dofetilide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Farmak A.S
ChemWerth Inc
Sun Pharmaceutical Industries Ltd.
Avet Pharmaceuticals Inc.
Midas Pharma
DQA Pharma
Segment by Type
Above 99.0%
Above 98.0%
Segment by Application
Capsules
Others
Production by Region
North America
Europe
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dofetilide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dofetilide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dofetilide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
1 Dofetilide API Market Overview
1.1 Product Definition
1.2 Dofetilide API Segment by Type
1.2.1 Global Dofetilide API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Above 99.0%
1.2.3 Above 98.0%
1.3 Dofetilide API Segment by Application
1.3.1 Global Dofetilide API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Capsules
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Dofetilide API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Dofetilide API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Dofetilide API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Dofetilide API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Dofetilide API Production Market Share by Manufacturers (2018-2023)
2.2 Global Dofetilide API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Dofetilide API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Dofetilide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Dofetilide API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Dofetilide API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Dofetilide API, Product Offered and Application
2.8 Global Key Manufacturers of Dofetilide API, Date of Enter into This Industry
2.9 Dofetilide API Market Competitive Situation and Trends
2.9.1 Dofetilide API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Dofetilide API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Dofetilide API Production by Region
3.1 Global Dofetilide API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Dofetilide API Production Value by Region (2018-2029)
3.2.1 Global Dofetilide API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Dofetilide API by Region (2024-2029)
3.3 Global Dofetilide API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Dofetilide API Production by Region (2018-2029)
3.4.1 Global Dofetilide API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Dofetilide API by Region (2024-2029)
3.5 Global Dofetilide API Market Price Analysis by Region (2018-2023)
3.6 Global Dofetilide API Production and Value, Year-over-Year Growth
3.6.1 North America Dofetilide API Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Dofetilide API Production Value Estimates and Forecasts (2018-2029)
3.6.3 India Dofetilide API Production Value Estimates and Forecasts (2018-2029)
4 Dofetilide API Consumption by Region
4.1 Global Dofetilide API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Dofetilide API Consumption by Region (2018-2029)
4.2.1 Global Dofetilide API Consumption by Region (2018-2023)
4.2.2 Global Dofetilide API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Dofetilide API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Dofetilide API Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Dofetilide API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Dofetilide API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Dofetilide API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Dofetilide API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Dofetilide API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Dofetilide API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Dofetilide API Production by Type (2018-2029)
5.1.1 Global Dofetilide API Production by Type (2018-2023)
5.1.2 Global Dofetilide API Production by Type (2024-2029)
5.1.3 Global Dofetilide API Production Market Share by Type (2018-2029)
5.2 Global Dofetilide API Production Value by Type (2018-2029)
5.2.1 Global Dofetilide API Production Value by Type (2018-2023)
5.2.2 Global Dofetilide API Production Value by Type (2024-2029)
5.2.3 Global Dofetilide API Production Value Market Share by Type (2018-2029)
5.3 Global Dofetilide API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Dofetilide API Production by Application (2018-2029)
6.1.1 Global Dofetilide API Production by Application (2018-2023)
6.1.2 Global Dofetilide API Production by Application (2024-2029)
6.1.3 Global Dofetilide API Production Market Share by Application (2018-2029)
6.2 Global Dofetilide API Production Value by Application (2018-2029)
6.2.1 Global Dofetilide API Production Value by Application (2018-2023)
6.2.2 Global Dofetilide API Production Value by Application (2024-2029)
6.2.3 Global Dofetilide API Production Value Market Share by Application (2018-2029)
6.3 Global Dofetilide API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Farmak A.S
7.1.1 Farmak A.S Dofetilide API Corporation Information
7.1.2 Farmak A.S Dofetilide API Product Portfolio
7.1.3 Farmak A.S Dofetilide API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Farmak A.S Main Business and Markets Served
7.1.5 Farmak A.S Recent Developments/Updates
7.2 ChemWerth Inc
7.2.1 ChemWerth Inc Dofetilide API Corporation Information
7.2.2 ChemWerth Inc Dofetilide API Product Portfolio
7.2.3 ChemWerth Inc Dofetilide API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 ChemWerth Inc Main Business and Markets Served
7.2.5 ChemWerth Inc Recent Developments/Updates
7.3 Sun Pharmaceutical Industries Ltd.
7.3.1 Sun Pharmaceutical Industries Ltd. Dofetilide API Corporation Information
7.3.2 Sun Pharmaceutical Industries Ltd. Dofetilide API Product Portfolio
7.3.3 Sun Pharmaceutical Industries Ltd. Dofetilide API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
7.3.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.4 Avet Pharmaceuticals Inc.
7.4.1 Avet Pharmaceuticals Inc. Dofetilide API Corporation Information
7.4.2 Avet Pharmaceuticals Inc. Dofetilide API Product Portfolio
7.4.3 Avet Pharmaceuticals Inc. Dofetilide API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Avet Pharmaceuticals Inc. Main Business and Markets Served
7.4.5 Avet Pharmaceuticals Inc. Recent Developments/Updates
7.5 Midas Pharma
7.5.1 Midas Pharma Dofetilide API Corporation Information
7.5.2 Midas Pharma Dofetilide API Product Portfolio
7.5.3 Midas Pharma Dofetilide API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Midas Pharma Main Business and Markets Served
7.5.5 Midas Pharma Recent Developments/Updates
7.6 DQA Pharma
7.6.1 DQA Pharma Dofetilide API Corporation Information
7.6.2 DQA Pharma Dofetilide API Product Portfolio
7.6.3 DQA Pharma Dofetilide API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 DQA Pharma Main Business and Markets Served
7.6.5 DQA Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Dofetilide API Industry Chain Analysis
8.2 Dofetilide API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Dofetilide API Production Mode & Process
8.4 Dofetilide API Sales and Marketing
8.4.1 Dofetilide API Sales Channels
8.4.2 Dofetilide API Distributors
8.5 Dofetilide API Customers
9 Dofetilide API Market Dynamics
9.1 Dofetilide API Industry Trends
9.2 Dofetilide API Market Drivers
9.3 Dofetilide API Market Challenges
9.4 Dofetilide API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer